Hookipa Pharma (HOOK) Competitors

Hookipa Pharma (NASDAQ:HOOK) and Anixa Biosciences (NASDAQ:ANIX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, earnings, analyst recommendations, media sentiment, community ranking, institutional ownership and valuation.

Does the media prefer HOOK or ANIX?

In the previous week, Anixa Biosciences had 1 more articles in the media than Hookipa Pharma. MarketBeat recorded 1 mentions for Anixa Biosciences and 0 mentions for Hookipa Pharma. Hookipa Pharma's average media sentiment score of 0.00 equaled Anixa Biosciences'average media sentiment score.

Company	Overall Sentiment
Hookipa Pharma	Neutral
Anixa Biosciences	Neutral

Do analysts prefer HOOK or ANIX?

Hookipa Pharma presently has a consensus price target of $23.00, indicating a potential upside of 1,237.99%. Anixa Biosciences has a consensus price target of $8.50, indicating a potential upside of 176.96%. Given Hookipa Pharma's higher probable upside, equities analysts clearly believe Hookipa Pharma is more favorable than Anixa Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hookipa Pharma	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Anixa Biosciences	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.33

Is HOOK or ANIX more profitable?

Anixa Biosciences has a net margin of 0.00% compared to Hookipa Pharma's net margin of -86.74%. Hookipa Pharma's return on equity of -33.31% beat Anixa Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hookipa Pharma	-86.74%	-33.31%	-21.65%
Anixa Biosciences	N/A	-58.55%	-53.29%

Does the MarketBeat Community favor HOOK or ANIX?

Hookipa Pharma received 65 more outperform votes than Anixa Biosciences when rated by MarketBeat users. However, 72.22% of users gave Anixa Biosciences an outperform vote while only 69.47% of users gave Hookipa Pharma an outperform vote.

Company	Underperform	Outperform
Hookipa Pharma	Outperform Votes 91 69.47%	Underperform Votes 40 30.53%
Anixa Biosciences	Outperform Votes 26 72.22%	Underperform Votes 10 27.78%

Which has more volatility and risk, HOOK or ANIX?

Hookipa Pharma has a beta of 0.72, indicating that its stock price is 28% less volatile than the S&P 500. Comparatively, Anixa Biosciences has a beta of 0.93, indicating that its stock price is 7% less volatile than the S&P 500.

Which has stronger earnings & valuation, HOOK or ANIX?

Anixa Biosciences has lower revenue, but higher earnings than Hookipa Pharma. Anixa Biosciences is trading at a lower price-to-earnings ratio than Hookipa Pharma, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hookipa Pharma	$20.13M	1.03	-$81.58M	-$3.72	-0.46
Anixa Biosciences	$210K	470.58	-$12.55M	-$0.39	-7.87

Do institutionals and insiders hold more shares of HOOK or ANIX?

63.9% of Hookipa Pharma shares are held by institutional investors. Comparatively, 29.1% of Anixa Biosciences shares are held by institutional investors. 3.3% of Hookipa Pharma shares are held by insiders. Comparatively, 22.6% of Anixa Biosciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Anixa Biosciences beats Hookipa Pharma on 11 of the 18 factors compared between the two stocks.